Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
T cells are required for normal host defense against fungal infection, and individuals with T cell-deficiency syndromes are highly susceptible to fungal pathogens. Interleukin (IL)-17A is a proinflammatory cytokine that interconnects myeloid and lymphoid host defense. The role of murine (m) IL-17A/mIL-17A receptor (R) interactions was evaluated in a murine model of systemic candidiasis. In response to systemic challenge with Candida albicans, expression of mIL-17A was induced, and IL-17AR knockout (IL-17AR(-/-)) mice had dose-dependent, substantially reduced survival. Fungal burden in the kidneys of IL-17AR(-/-) mice was dramatically increased (25-fold at 96 h). In IL-17AR(-/-) mice, both mobilization of peripheral neutrophils and their influx to infected organs were significantly impaired and delayed. In vivo expression of mIL-17A protected normal mice from a lethal dose of C. albicans (100% at day 7 and 65% at day 42). The data suggest that the mIL-17A/mIL-17AR system is required for normal fungal host defense in vivo. IL-17A could have potential as a therapeutic cytokine for systemic C. albicans infections in immunocompromised patients with cancer or advanced acquired immunodeficiency syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Confirming previous reports, IL-17RA-/- mice demonstrated significantly increased kidney fungal burden in comparison to WT following infection with C. albicans (CAF2-1 or SC5314) (Fig 1A) [14,16,33].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17RA-/-, IL-17RC-/-, RORγt-/- and IL-17A-/- mice are all susceptible to systemic C. albicans infection [14–17].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“During candidiasis, IL-17 is rapidly upregulated in the kidney, but its function in that organ is unknown [14].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17 is a key mediator of defense against candidiasis.”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“In recent years, considerable data have implicated IL-17 in immunity against disseminated candidiasis [14–16].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
Self-citationTrends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657 · cited 1×
“suppressive cancer chemotherapy, especially if this treatment is followed by prolonged periods of neutropenia, such as seen in bone marrow transplantation [1, 2].”
BackgroundIL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597 · cited 1×
“tem, because of its unique effects [14].”
Interleukin-17 and Lung Host Defense against Klebsiella pneumoniae Infection
Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., & Kolls, J. K. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4424 · Cited by 461 · cited 2×
“Although statistically significant, this finding was less pronounced than that observed in our previous studies of gram-negative bacteria challenge, in which IL17AR / mice failed entirely to mount a peripheral neutrophil response [8, 9].”
ResultSelf-citationSchwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6383 · Cited by 325 · cited 5×
“neutrophils and their precursors [7, 9] (data not shown).”
BackgroundMethodInfluentialSelf-citationAntibody response that protects against disseminated candidiasis
Han, Y., & Cutler, J. E. (1995) · Infection and Immunity · doi:10.1128/iai.63.7.2714-2719.1995 · Cited by 308 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
BackgroundCAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA
CHANG, H.-Y., RODRIGUEZ, V., NARBONI, G., BODEY, G. P., LUNA, M. A., & FREIREICH, E. J. (1976) · Medicine · doi:10.1097/00005792-197605000-00005 · Cited by 301 · cited 2×
“individuals [1, 5].”
Schwarzenberger, P., Huang, W., Ye, P., Oliver, P., Manuel, M., Zhang, Z., Bagby, G., Nelson, S., & Kolls, J. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4783 · Cited by 277 · cited 1×
“mIL-17A was found to exert significant effects on neutrophils and its precursors, not directly, but, to a large extent, via the induction and release of secondary or downstream cytokines from stromal cells [7, 15].”
BackgroundSelf-citationInfectious Complications of Chronic Lymphocytic Leukemia
WADHWA, P., & MORRISON, V (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.013 · Cited by 276 · cited 1×
“related to clinical outcomes [5, 6].”
Bacteremia and Fungemia in Patients with the Acquired Immunodeficiency Syndrome
WHIMBEY, E., GOLD, J. W. M., POLSKY, B., DRYJANSKI, J., HAWKINS, C., BLEVINS, A., BRANNON, P., KIEHN, T. E., BROWN, A. E., & ARMSTRONG, D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-511 · Cited by 239 · cited 3×
“The data are encouraging for pursuing further development of mIL-17A in fungal infections, which could benefit immunocompromised individuals, especially patients with cancer or AIDS.”
Background
Cited by
Items 501–600 of 858
Lactobacillus rhamnosus intake can prevent the development of Candidiasis
Leão, M. V. P., Tavares, T. A. A., Silva, C. R. G. E., dos Santos, S. S. F., Junqueira, J. C., de Oliveira, L. D., & Jorge, A. O. C. (2018) · Clinical Oral Investigations · doi:10.1007/s00784-018-2347-8 · Cited by 34
Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species
Wadhwa, R., Pandey, P., Gupta, G., Aggarwal, T., Kumar, N., Mehta, M., Satija, S., Gulati, M., Madan, J., Dureja, H., et al. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191026105308 · Cited by 30
Neely, C. J., Maile, R., Wang, M.-J., Vadlamudi, S., Meyer, A. A., & Cairns, B. A. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31820d18a6 · Cited by 28
Dendritic cell interactions withHistoplasmaandParacoccidioides
Thind, S. K., Taborda, C. P., & Nosanchuk, J. D. (2015) · Virulence · doi:10.4161/21505594.2014.965586 · Cited by 36
“IL-17A acts on a variety of cell types to promote inflammation(82) and helps eradicate extracellular pathogens.(83) Interestingly, blockade of IL-17A has been shown to aggravate pulmonary histoplasmosis,(84) suggesting that this interleukin promotes antifungal activity.”
BackgroundMizunoe, S., Shuto, T., Suzuki, S., Matsumoto, C., Watanabe, K., Ueno-Shuto, K., Suico, M. A., Onuki, K., Gruenert, D. C., & Kai, H. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11240fp · Cited by 27
Alterations of serum cytokine levels and their relation with inflammatory markers in candidemia
Akın, H., Akalın, H., Budak, F., Ener, B., Ocakoğlu, G., Gürcüoğlu, E., Göral, G., & Oral, H. B. (2015) · Medical Mycology · doi:10.1093/mmy/myu084 · Cited by 28
“albicans infection [33].”
Interferon-gamma Immunotherapy in a Patient With Refractory Disseminated Candidiasis
Buddingh, E. P., Leentjens, J., van der Lugt, J., Dik, W. A., Gresnigt, M. S., Netea, M. G., Pickkers, P., & Driessen, G. J. A. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000909 · Cited by 29
Profile of secukinumab in the treatment of psoriasis: current perspectives
Chiu, M. W., Madkan, V. K., & Roman, M. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s79053 · Cited by 31
“albicans infections in immunocompromised patients with cancer or advanced acquired immunodeficiency syndrome.(32) This finding provides a strong explanation for why a higher percentage of patients in the secukinumab treatment groups experienced Candida infections.”
Dong, R., Zhang, Y., Zhu, L., Liu, H.-L., Liu, J., Kuang, Y., Wang, R.-R., & Li, Y. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz205 · Cited by 25
“IL-17A could enhance host defenses against invading fungi, including Cryptococcus neoformans, Aspergillus, and Histoplasma capsulatum by affecting leukocyte recruitment, IFN-γ production, and antimicrobial peptides [31, 32].”
BackgroundWang, H., Li, Z.-T., Yang, B.-Y., Yu, S.-F., & Wu, C.-Y. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.05.001 · Cited by 25
Vasoactive Intestinal Peptide–Mediated Th17 Differentiation
Yadav, M., & Goetzl, E. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.020 · Cited by 26
Sade, K., Fishman, G., Kivity, S., DeRowe, A., & Langier, S. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.575426 · Cited by 26
“There is considerable evidence that IL-17 is important in host responses to infection (Aujla et al., 2008; Brenchley et al., 2008; Eyerich et al., 2008; Huang et al., 2004; Ishigame et al., 2009).”
BackgroundT‐helper 17 cell: A distinctive cell in liver diseases
Ye, C., Li, W., Zheng, M., & Chen, Y. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00744.x · Cited by 28
Spalinger, M. R., Schwarzfischer, M., Hering, L., Shawki, A., Sayoc, A., Santos, A. N., Gottier, C., Lang, S., Bäbler, K., Geirnaert, A., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0201-1 · Cited by 27
IL-17F/IL-17R interaction stimulates granulopoiesis in mice
Tan, W., Huang, W., Gu, X., Zhong, Q., Liu, B., & Schwarzenberger, P. O. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.06.003 · Cited by 25
“albicans (ATCC 14053) were followed [21].”
Self-citationLocal antifungal immunity in the kidney in disseminated candidiasis
Jawale, C. V., & Biswas, P. S. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.04.005 · Cited by 25
A young girl with severe cerebral fungal infection due to card 9 deficiency
Çetinkaya, P. G., Cağdaş, D. N., Karaatmaca, B., Göçmen, R., Söylemezoğlu, F., Bainter, W., Chou, J. S., Chatila, T. A., & Tezcan, İ. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.01.002 · Cited by 28
Immune Regulation and Tolerance to Fungi in the Lungs and Skin
Romani, L., & Puccetti, P. (2008) · Chemical Immunology and Allergy · doi:10.1159/000154957 · Cited by 25
Sampaio, P., Santos, M., Correia, A., Amaral, F. E., Chávez-Galarza, J. C., Costa‐de‐Oliveira, S., Castro, A. G., Pedrosa, J., & Pais, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010155 · Cited by 32
“previous reports, indicating that pro-inflammatory cytokines are important for antifungal effector functions, particularly during the early phase of the inflammatory response [12,33,34,44,45].”
BackgroundO’Connell, A. E., Redding, K., Hess, J. A., Lok, J. B., Nolan, T. J., & Abraham, D. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.01.016 · Cited by 25
“This suggests that, unlike many other infectious agents [11,12,16], IL-17R is not required for neutrophil recruitment to larval S.”
BackgroundHelicobacter pylori vaccination: Is there a path to protection?
Anderl, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.11939 · Cited by 27
Cracking the Toll-like receptor code in fungal infections
Cunha, C., Romani, L. R., & Carvalho, A. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.93 · Cited by 29
Yang, W. C., Ding, X., Deng, J., Lu, Y., Matsuda, Z., Thiel, A., Chen, J., Deng, H., & Qin, Z. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0711-5 · Cited by 24
“Indeed, IL-17 is known to be induced and required for the host protection against Klebsiella pneumoniae [21], Citrobacter rodentium [22], and Candida albicans [23].”
BackgroundHuman gain-of-function STAT1 mutation disturbs IL-17 immunity in mice
Tamaura, M., Satoh‐Takayama, N., Tsumura, M., Sasaki, T., Goda, S., Kageyama, T., Hayakawa, S., Kimura, S., Asano, T., Nakayama, M., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz079 · Cited by 30
Dallenbach, K., Maurer, P., Röhn, T. A., Zabel, F., Köpf, M., & Bachmann, M. F. (2014) · European Journal of Immunology · doi:10.1002/eji.201445017 · Cited by 25
Immunovirological parameters and cytokines in HIV infection
Tasca, K. I., Calvi, S. A., & de Souza, L. D. R. (2012) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822012000600002 · Cited by 25
Chin, V. K., Foong, K.-J., MAHA, A., Basir, R., Norhafizah, M. Z., & Chong, P. P. (2014) · Biomedical Reports · doi:10.3892/br.2014.365 · Cited by 29
“A previous study has shown the involvement of the Th17 response in systemic candidiasis and the Th17 response has a clear protective effect in disseminated murine C. albicans infection, where IL-17a receptor-knockout mice resulted in reduced survival and increased fungal burden in the kidneys (17).”
ICOS ligand expression is essential for allergic airway hyperresponsiveness
Kadkhoda, K., Wang, S., Fan, Y., Qiu, H., Basu, S., Halayko, A. J., & Yang, X. (2011) · International Immunology · doi:10.1093/intimm/dxq476 · Cited by 25
Shen, H., Chen, S. M., Liu, W., Zhu, F., He, L. J., Zhang, J. D., Zhang, S. Q., Yan, L., Xu, Z., Xu, G. T., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00097-15 · Cited by 24
Niu, J., Guo, Y., Jing, G., Wang, H., Yang, L., Li, Y., Gao, Y., Wang, H., Li, A., Xu, X., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305042 · Cited by 27
Increased Frequency of Th17 Cells in Children With Mycoplasma pneumoniae Pneumonia
Wang, X., Chen, X., Tang, H., Zhu, J., Zhou, S., Xu, Z., Liu, F., & Su, C. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22005 · Cited by 23
Dehghan, P., Tolouie, S., Baradaran, B., Nami, S., & Morovati, H. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.04.026 · Cited by 23
Controlling Candida : immune regulation of commensal fungi in the gut
Jensen, O., Trujillo, E. N., Hanson, L., & Ost, K. S. (2024) · Infection and Immunity · doi:10.1128/iai.00516-23 · Cited by 24
“Anti-Candida Th17 immunity has been well established in protection against systemic (104–106) and oral candidiases (107, 108), which has been thoroughly examined by a number of excellent reviews (99, 109).”
BackgroundAzevedo, M. D. C. S., Rosa, P. S., Soares, C. T., Fachin, L. R. V., Baptista, I. M. F. D., Woods, W. J., Garlet, G. P., Trombone, A. P. F., & Belone, A. D. F. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145814 · Cited by 23
“Some studies show that Th17 cells play a protective role in the control of fungal infections [26,30,31], while other studies associate the Th17 response to the organism’s survival and multiplication [32,33,34].”
BackgroundResultDiagnosis and inflammatory response of patients with candiduria
Helbig, S., Achkar, J. M., Jain, N., Wang, X., Gialanella, P., Levi, M. H., & Fries, B. C. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02201.x · Cited by 22
Wu, V., Smith, A. A., You, H., Nguyen, T. A., Ferguson, R., Taylor, M., Park, J. E., Llontop, P., Youngman, K. R., & Abramson, T. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.101 · Cited by 22
Guo, Y. J., Sun, X., Shibata, K., Yamada, H., Muta, H., Podack, E. R., & Yoshikai, Y. (2013) · Infection and Immunity · doi:10.1128/iai.00887-13 · Cited by 24
Li, X., Yang, Y., Yang, F., Wang, F., Li, H., Tian, H., & Wang, G. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.105 · Cited by 21
Hyphal Als proteins act as CR3 ligands to promote immune responses against Candida albicans
Zhou, T., Solis, N. V., Marshall, M., Yao, Q., Garleb, R., Yang, M., Pearlman, E., Filler, S. G., & Liu, H. (2024) · Nature Communications · doi:10.1038/s41467-024-48093-8 · Cited by 21
“What are the dotted lines in fig 1b and 1c? d. Lines 123-4 “The amount of fungal-induced cell death…independent” Insert “was” e. Lines 130-135.”
The enduring tale of T cells in HIV immunopathogenesis.
Vajpayee, M., Negi, N., & Kurapati, S. (2013) · PubMed Central · Cited by 26
Severely depressed interleukin-17 production by human neonatal mononuclear cells
Caron, J. E., Pine, T. R. L., Augustine, N. H., Martins, T. B., Kumánovics, A., & Hill, H. R. (2014) · Pediatric Research · doi:10.1038/pr.2014.133 · Cited by 21
Secukinumab for treating plaque psoriasis
Rothstein, B. E., & Gottlieb, A. B. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1121986 · Cited by 26
“As discussed above, mice deficient in the IL-17A receptor are more susceptible to Candida albicans infections.[61,62] Patients with Autoimmune polyendocrine syndrome type 1 experience increased susceptibility to chronic mucocutaneous candidiasis.”
BackgroundUpregulation of duck interleukin-17A during Riemerella anatipestifer infection
Fernandez, C. P., Kim, W. H., Diaz, J. A. R., Jeong, J., Afrin, F., Kim, S., Jang, H., Lee, B.-H., Yim, D., Lillehoj, H. S., et al. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.05.009 · Cited by 23
Smeekens, S. P., Henriet, S. S. V., Gresnigt, M. S., Joosten, L. A. B., Hermans, P. W. M., Netea, M. G., Warris, A., & van de Veerdonk, F. L. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0046 · Cited by 20
Roles of Th17 cells in pulmonary granulomas induced by Schistosoma japonicum in C57BL/6 mice
Chen, D., Xie, H., Luo, X., Yu, X., Fu, X., Gu, H., Wu, C. Y., Tang, X., & Huang, J. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.09.008 · Cited by 20
“It has been reported to participate in host defense against various types of pathogens [9,10] and thought to be an important cytokine in the immune response against S.”
BackgroundEffects of the Commercial Flame Retardant Mixture DE-71 on Cytokine Production by Human Immune Cells
Kronborg, T. M., Hansen, J. F., Nielsen, C. H., Ramhøj, L., Frederiksen, M., Vorkamp, K., & Feldt‐Rasmussen, U. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154621 · Cited by 20
“The apparent skewing of T-cell responses towards a Th1-response, and away from Th17 responses might indicate that defence against infection with extracellular bacteria and fungi, which normally requires Th17 responses [26, 27], may be compromised by DE-71.”
BackgroundLes cellules Th17: Une nouvelle population de cellules T CD4 effectrices pro-inflammatoires
Leung–Theung–Long, S., & Guerder, S. (2008) · médecine/sciences · doi:10.1051/medsci/20082411972 · Cited by 24
Sabat, R., Witte, E., Witte, K., & Wolk, K. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_2 · Cited by 23
“Indeed, as demonstrated by means of IL17RA-deficient animals, IL-17 was critical for the protection against Klebsiella pneumoniae [134], Citrobacter rodentium (in later stages) [88], Toxoplasma gondii [135], and systemic and oropharyngeal candidiasis [136, 137].”
BackgroundThe inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16
Gras, R., Relloso, M., García, M. I., de la Mata, F. J., Gómez, R., López-Fernández, L. A., & Muñoz‐Fernández, M. Á. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.018 · Cited by 20
“albicans and eventually succumb to the pathogen since theywere no able to clear the fungal infection [10].”
BackgroundInsights from human studies into the host defense against candidiasis
Filler, S. G. (2012) · Cytokine · doi:10.1016/j.cyto.2011.09.018 · Cited by 19
“For example, IL-17RA−/− mice with disseminated candidiasis have accelerated mortality, increased organ fungal burden, and reduced neutrophil accumulation in infected organs as compared to wild-type control mice [16].”
BackgroundLi, T., Niu, X., Zhang, X., Wang, S., & Liu, Z. (2016) · AMB Express · doi:10.1186/s13568-016-0281-1 · Cited by 19
“Moreover, evidence has been mounting that a Th17driven immune response plays a predominant role in modulating a defensive mucosal immune response against Candida in both mice and humans (Huang et al. 2004; Conti et al. 2009; Eyerich et al. 2008).”
BackgroundTengesdal, I. W., Kitzenberg, D., Li, S., Nyuydzefe, M. S., Chen, W., Weiss, J. M., Zhang, J., Waksal, S. D., Zanin‐Zhorov, A., & Dinarello, C. A. (2018) · European Journal of Immunology · doi:10.1002/eji.201847652 · Cited by 19
Ivanov, S., & Lindén, A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.2.279 · Cited by 19
da Silva, T. A., Mariano, V. S., Sardinha-Silva, A., de Souza, M. A., Mineo, T. W. P., & Roque‐Barreira, M. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149721 · Cited by 19
“albicans) [12], which demonstrated the role of Toll-Like Receptor-2 (TLR2)/Dectin-1 pathway in the production of IL-17 during the fungal infection [13].”
BackgroundEarly activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis
Saunus, J. M., Wagner, S. A., Matias, M. A. T. J., Hu, Y., Zaini, Z. M., & Farah, C. S. (2010) · Molecular Oral Microbiology · doi:10.1111/j.2041-1014.2010.00570.x · Cited by 22
IL‐23 and IL‐17 have a multi‐faceted largely negative role in fungal infection
Cooper, A. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737804 · Cited by 19
Anti‐cytokine vaccines and the immunotherapy of autoimmune diseases
Wraith, D. C. (2006) · European Journal of Immunology · doi:10.1002/eji.200636760 · Cited by 20
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis
Reich, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1205835 · Cited by 18
T cell immune responses in psoriasis.
Jadali, Z., & Eslami, M. R. (2014) · PubMed · Cited by 29
Mou, Z., Jia, P., Kuriakose, S. M., Khadem, F., & Uzonna, J. E. (2010) · Infection and Immunity · doi:10.1128/iai.00168-10 · Cited by 23
“This observation is consistent with previous reports showing that IL-17 plays a protective role in several infectious diseases (2, 9, 14, 34).”
BackgroundResultT cell Immunity and Vaccines Against Invasive Fungal Diseases
Ito, J. I. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.595472 · Cited by 21
“Animals studies have shown that mice deficient in IL-17RA have an increased susceptibility to disseminated candidiasis (Huang et al., 2004), and IL-17A induced by dectin-2 is necessary for defense against IC (Saijo et al.”
BackgroundShroff, A., Sequeira, R., Patel, V. V., & Reddy, K. V. R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.012 · Cited by 18
Prevalence of Candida species in Psoriasis
Elsner, K., Holstein, J., Hilke, F. J., Blumenstock, G., Walker, B., Schmidt, S., Schaller, M., Ghoreschi, K., & Meier, K. (2021) · Mycoses · doi:10.1111/myc.13399 · Cited by 18
Interleukin inhibitors and the associated risk of candidiasis
Khan, S., Bilal, H., Khan, M. N., Fang, W., Chang, W., Yin, B., Song, N., Liu, Z., Zhang, D., Yao, F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372693 · Cited by 22
Rajkovic, I., Dragicevic, A., Vasilijić, S., Nedeljković, B. B., Džopalić, T., Tomić, S., Majstorović, I., Vučević, D., Đokić, J., Balint, B., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03356.x · Cited by 21
Perona‐Wright, G., Lundie, R. J., Jenkins, S. J., Webb, L. M., Grencis, R. K., & MacDonald, A. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101642 · Cited by 18
“litis (18, 19), arthritis (20), and fungal (21, 22) and bacterial infections (23, 24).”
BackgroundImmune Response To Aspergillus Fumigatus In Compromised Hosts: From Bedside To Bench
Chai, L. Y., Vonk, A. G., Kullberg, B. J., & Netea, M. G. (2010) · Future Microbiology · doi:10.2217/fmb.10.158 · Cited by 21
Mosci, P., Gabrielli, E., Luciano, E., Perito, S., Cassone, A., Pericolini, E., & Vecchiarelli, A. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.06.007 · Cited by 19
Chou, C.-W., Lin, F.-C., Tsai, H.-C., & Chang, S.-C. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-182 · Cited by 17
“Impaired IL-17 response was reported to be associated with decreased clearance of Candida and Aspergillus [21,22].”
BackgroundPonichtera, H. E., & Stadecker, M. J. (2015) · Experimental Parasitology · doi:10.1016/j.exppara.2015.04.006 · Cited by 17
“Importantly, Th17 cells were also found to be key mediators of pathology in many autoimmune and infectious diseases (Curtis and Way, 2009; Di Cesare et al., 2009; Huang et al., 2004; Iwakura et al., 2008; Langrish et al., 2005; Murphy et al., 2003).”
BackgroundNarita, K., Hu, D., Asano, K., & Nakane, A. (2019) · Infection and Immunity · doi:10.1128/iai.00494-19 · Cited by 19
“Klebsiella pneumoniae (7), Streptococcus pyogenes (8), and Candida albicans (9), through Citation Narita K, Hu D-L, Asano K, Nakane A.”
BackgroundFriend or Foe – Tc17 cell generation and current evidence for their importance in human disease
Hipp, A. V., Bengsch, B., & Globig, A.-M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad010 · Cited by 18
“Mechanistically, IL-17 receptor signaling is responsible for the timely and localized migration of neutrophils to infected organs and for the production of antimicrobial peptides and chemokines [11, 170, 171].”
BackgroundOrr, S. J., Burg, A. R., Chan, T., Quigley, L., Jones, G. W., Ford, J. W., Hodge, D. L., Razzook, C., Sarhan, J., Jones‐Hall, Y., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003357 · Cited by 17
“More recently, fungal responses have been shown to involve the Th17 pathway; Il23a, Il17ra and Il17a mice are more susceptible to oral and/or systemic candidiasis [6,11,12].”
BackgroundColonization and effector functions of innate lymphoid cells in mucosal tissues
Kim, M., & Kim, C. H. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.06.005 · Cited by 16
Khanum, S., Carbone, V., Gupta, S. K., Yeung, J. H. F., Shu, D., Wilson, T., Parlane, N. A., Altermann, E., Estein, S. M., Janssen, P. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14545-8 · Cited by 22
IL-23 and Th17 cells in infections and psoriasis
Kagami, S. (2011) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.34.13 · Cited by 16
Marijnissen, R. J., Koenders, M. I., van de Veerdonk, F. L., Dulos, J., Netea, M. G., Boots, A. M. H., Joosten, L. A. B., & van den Berg, W. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038889 · Cited by 19
Kundu, G., & Noverr, M. C. (2010) · Medical Mycology · doi:10.3109/13693786.2010.532514 · Cited by 19
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
Dao, H., & Ren, V. Z. (2013) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s42424 · Cited by 16
Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation
Cunha, C., Rodrigues, F. J. S., Zelante, T., Aversa, F., Romani, L. R., & Carvalho, A. (2010) · Medical Mycology · doi:10.3109/13693786.2010.508797 · Cited by 19
Emerging roles of the Th17/IL-17-axis in glomerulonephritis
Ramani, K., & Biswas, P. S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.029 · Cited by 17
Regulation of Interleukin-23 Expression in Health and Disease
Welsby, I., & Goriely, S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_8 · Cited by 21
Tilg, H., Moschen, A. R., & Kaser, A. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0141 · Cited by 16
“, Candida and others can induce a strong Th17 response [29, 30].”
BackgroundMucosal Immunity andCandidaalbicans Infection
Wing, T. (2011) · Cited by 16
The Role of IL-17 During Infections in the Female Reproductive Tract
Bagri, P., Anipindi, V. C., & Kaushic, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861444 · Cited by 22
“Similarly, animal studies have shown that in the absence of IL-17 and/or IL-17mediated signalling, mice demonstrated worsened disease outcomes following both systemic (39) and oral infection with C.”
BackgroundShaikh, M. O. F., Schaefers, M. M., Merakou, C., DiBlasi, M. J., Bonney, S. L., Liao, T., Zurakowski, D., Kehl, M., Tabor, D. E., DiGiandomenico, A., et al. (2022) · Infection and Immunity · doi:10.1128/iai.00203-22 · Cited by 15
“Th17 208 responses are essential for host defense against a number of pathogens, including Salmonella 209 enterica (33), Streptococcus pneumoniae (34), Klebsiella pneumoniae (35), Staphylococcus 210 aureus (36, 37), Mycobacterium tuberculosis (38), and Candida albicans (39).”
BackgroundGracci, S., Novelli, T., D’Elios, S., Bernardini, R., & Peroni, D. G. (2023) · Current Pediatric Reviews · doi:10.2174/1573396320666230912103124 · Cited by 19
Gastrointestinal Colonization of Fungi
Koh, A. Y. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0133-2 · Cited by 18
Alvarez-Rueda, N., Rouges, C., Touahri, A., Misme‐Aucouturier, B., Albassier, M., & Pape, P. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63344-6 · Cited by 17
Regulation of Protective and Pathogenic Th17 Responses
Alber, G., & Kamradt, T. (2007) · Current Immunology Reviews · doi:10.2174/157339507779802223 · Cited by 25
Requirement of TPO/c-mpl for IL-17A-induced granulopoiesis and megakaryopoiesis
Tan, W., Liu, B., Barsoum, A. L., Huang, W., Kolls, J. K., & Schwarzenberger, P. O. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212639 · Cited by 14
“Upon microbial challenge, IL-17AR / animals fail to respond with appropriate emergency granulopoiesis and neutrophil stimulation [17, 18].”
BackgroundSelf-citationStaphylococcus aureus Colonization Induces Strain-Specific Suppression of Interleukin-17
Reiss-Mandel, A., Rubin, C., Zayoud, M., Rahav, G., & Regev‐Yochay, G. (2018) · Infection and Immunity · doi:10.1128/iai.00834-17 · Cited by 14
Arumugam, G., & Rajaram, R. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.119 · Cited by 14
Zhou, C., Monin, L., Gordon, R. A., Aggor, F. E. Y., Bechara, R., Edwards, T. N., Kaplan, D. H., Gingras, S., & Gaffen, S. L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000394 · Cited by 14
Vultaggio, A., Lombardelli, L., Giudizi, M. G., Biagiotti, R., Mazzinghi, B., Scaletti, C., Mazzetti, M., Livi, C., Leoncini, F., Romagnani, S., et al. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.11.004 · Cited by 13
Kinetics of Th17 Cytokines During Telbivudine Therapy in Patients With Chronic Hepatitis B
Hao, C.-Q., Wang, J., Kang, W., Xie, Y., Zhou, Y., Ma, L., Peng, M., Bai, X., Lian, J., & Jia, Z. (2013) · Viral Immunology · doi:10.1089/vim.2013.0032 · Cited by 14
“IL-17 is also important in the host defense against extracellular bacteria such as Klebsiella pneumoniae (9), Bacteroides fragilis (6), or Mycobacterium tuberculosis (17), against virus such as hepatitis C virus (HCV) (35) and human immunodeficiency virus (HIV) (29), and against fungi such as Candida albicans (14).”
Hadley, K. B., Guimont‐Desrochers, F., Bailey‐Hall, E., Salem, N., Yurko‐Mauro, K., & Field, C. J. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.09.002 · Cited by 14
Niu, C.-Y., Cheng, C., Liu, Y., Huang, S.-L., Fu, Y.-R., & Li, P.-F. (2019) · mSystems · doi:10.1128/msystems.00268-19 · Cited by 15
Mirkov, I. I., Stojanović, I., Glamočlija, J., Stošić‐Grujičić, S., Zolotarevski, L. D., Kataranovski, D., & Kataranovski, M. V. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.04.007 · Cited by 20
Witkowski, S. M., de Castro, E. M., Nagashima, S., Martins, A. P. C., Okamoto, C. T., Nakata, G. T. M., Collete, M., Souza, C. M., & de Noronha, L. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155118 · Cited by 15
Metadata
- Authors
- Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P.
- Affiliations
- Louisiana State University Health Sciences Center New Orleans (US)
- Corresponding author
- Huang, Weitao
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 190
- Issue
- 3
- Pages
- 624-631
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2112133235
- Cited by
- 859
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 25 · 2023: 21 · 2022: 20 · 2021: 23 · 2020: 19 · 2019: 23 · 2018: 28 · 2017: 35 · 2016: 41 · 2015: 53 · 2014: 48 · 2013: 52 · 2012: 74
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA081125)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17 receptor, Candida albicans, systemic candidiasis, neutrophil recruitment, T cell-dependent immunity, immunocompromised patients
- MeSH terms
- Animals, Candida albicans, Candidiasis, Disease Models, Animal, Humans, Kidney, Mice, Inbred C57BL, Recombinant Proteins, Receptors, Interleukin, Mice, Knockout, Interleukin-17, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.